Marshall Wace’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-320,517
Closed -$3.29M – 2872
2023
Q2
$3.29M Hold
320,517
– – 0.01% 1195
2023
Q1
$3.24M Sell
320,517
-576,422
-64% -$5.81M 0.01% 1206
2022
Q4
$8.97M Hold
896,939
– – 0.02% 864
2022
Q3
$8.73M Hold
896,939
– – 0.02% 979
2022
Q2
$8.69M Hold
896,939
– – 0.02% 958
2022
Q1
$8.75M Buy
896,939
+492,500
+122% +$4.76M 0.02% 968
2021
Q4
$3.97M Buy
404,439
+4,439
+1% +$43.5K 0.01% 1545
2021
Q3
$3.93M Buy
+400,000
New +$3.95M 0.02% 1087

Marshall Wace's DALS Position: Q3 2023 in Review

Marshall Wace sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 320,517 shares — an estimated $3.29M sold.

Marshall Wace first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $8.97M in Q4 2022. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Marshall Wace reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 320,517 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $3.29M.
  • Marshall Wace first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 8 quarters.
  • Marshall Wace's DA32 Life Science Tech Acquisition Corp position peaked at $8.97M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.